PAC8 is a venture capital firm that invests in disruptive technology platforms and healthcare companies. PAC8 focuses on seed stage investments, primarily in the US market.

PAC8

Pacific 8 Ventures is a venture capital firm that invests at the nexus of cutting-edge technology platforms and biology/medicine. We focus on early-stage startups.

Our investments consist of high-performing companies in the area of synthetic biology, gene therapy, CRISPR, machine learning/artificial intelligence, digital therapeutics, and more.

Founders appreciate that we can be more than just a capital partner but also a strategic partner for market access given our LP and advisor base consists of groups that own and operate hospitals, clinics, health insurance, and life insurance companies.

Pacific 8 Ventures

Congratulations to Ashley Zehnder and the Fauna Bio team on being chosen from hundreds of nominees for Fierce Biotech’s 2024 Fierce 15 List! This fantastic recognition shines a spotlight on their innovative approach in harnessing the power of biology from other species to advance human health. Keep up the amazing work!

Congratulations to Empirical Health for launching Empirical 2.0, which integrates biometric data with medical AI to provide personalized healthcare!!!

Huge congratulations to Oguzhan Atay, PhD, David Tsao, and the exceptional BillionToOne team on securing $130 million in an oversubscribed Series D funding round. This funding will further revolutionize the prenatal screening and oncology diagnostics landscape.

We’re incredibly proud of the team and thrilled to have partnered with them on this exciting journey!!!

Congratulations to Trevor Martin, Janice Chen, Lucas Harrington and the Mammoth Biosciences team for securing another major gene-editing collaboration with Regeneron! This $100M upfront agreement is poised to develop in-vivo CRISPR-based gene editing therapies, broadening their potential to target various tissues beyond the liver. What an incredible achievement!!!

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 9, 2024 6:02 PM	9c3ffc58
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 9, 2024 6:02 PM	15c5a604
translate crunchbase fundingrounds	general
peers	general	Aug 9, 2024 6:02 PM	62fe51d3
news basic	general	Aug 9, 2024 6:02 PM	d486137e
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PAC8

COM:PAC8

PAC8